Efficacy and Safety of Tocilizumab

Jul 10, 2016 | Clinical trials

Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (Clinical trial)

Did you know, that you can look up clinical trials on scleroderma on following sites: 

For instance you can find following trial by Genentech:

A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc) [focuSSced]

Official title: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis.

The company is looking to enroll 210 patients in the following countries: Argentina, Belgium, Brazil, Bulgaria, Canada, Croatia, Denmark, France, Germany, Greece, Hungary, Italy, Lithuania, Japan, Mexico, Netherlands, Poland, Portugal, Romania, South Africa, Spain, Switzerland, UK, and USA.

 


FESCA news & eventsnews & events

Help us to keep smiling

We invite you from all over the world to post a picture/video with smiles on social medias like twitter, facebook, instagram etc with the hashtag #ScleroSmile

Share This